Clorox (NYSE:CLX – Get Free Report) had its price target boosted by investment analysts at Barclays from $85.00 to $86.00 in a note issued to investors on Tuesday,Benzinga reports. The brokerage currently has an “underweight” rating on the stock. Barclays‘s price target indicates a potential downside of 10.72% from the stock’s current price.
A number of other analysts also recently issued reports on the stock. Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a report on Friday, July 10th. JPMorgan Chase & Co. cut their price objective on Clorox from $95.00 to $92.00 and set an “underweight” rating on the stock in a research report on Thursday, July 16th. Zacks Research cut shares of Clorox from a “hold” rating to a “strong sell” rating in a report on Tuesday, May 12th. UBS Group increased their price objective on Clorox from $96.00 to $100.00 and gave the company a “neutral” rating in a report on Thursday, July 16th. Finally, Citigroup dropped their target price on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating on the stock in a research report on Friday, May 1st. One investment analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have issued a Sell rating to the company. According to data from MarketBeat, the company currently has an average rating of “Reduce” and a consensus target price of $103.40.
View Our Latest Stock Analysis on CLX
Clorox Trading Up 0.0%
Clorox (NYSE:CLX – Get Free Report) last posted its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, beating the consensus estimate of $1.55 by $0.09. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.67 billion. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm’s revenue was up .1% on a year-over-year basis. During the same period in the prior year, the company earned $1.45 earnings per share. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Equities analysts predict that Clorox will post 5.52 EPS for the current year.
Insider Transactions at Clorox
In other news, Director Pierre R. Breber acquired 5,000 shares of the company’s stock in a transaction on Tuesday, May 5th. The shares were bought at an average cost of $85.82 per share, with a total value of $429,100.00. Following the purchase, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. This represents a 38.46% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.63% of the company’s stock.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently made changes to their positions in CLX. Darwin Wealth Management LLC purchased a new position in Clorox during the second quarter worth about $29,000. Caitlin John LLC boosted its holdings in Clorox by 1,807.1% in the 4th quarter. Caitlin John LLC now owns 267 shares of the company’s stock valued at $27,000 after purchasing an additional 253 shares in the last quarter. Root Financial Partners LLC boosted its holdings in Clorox by 83.8% in the 1st quarter. Root Financial Partners LLC now owns 318 shares of the company’s stock valued at $33,000 after purchasing an additional 145 shares in the last quarter. Vision Financial Markets LLC increased its position in Clorox by 166.7% during the 4th quarter. Vision Financial Markets LLC now owns 320 shares of the company’s stock worth $32,000 after purchasing an additional 200 shares during the period. Finally, Western Wealth Management LLC acquired a new position in Clorox during the 1st quarter worth approximately $35,000. 78.53% of the stock is currently owned by institutional investors and hedge funds.
Clorox Company Profile
The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.
Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.
Read More
- Five stocks we like better than Clorox
- Buy, Hold, or Wait: 3 Small-Cap Stocks Telling Different Stories
- IBM Just Had Its Worst Day Ever—What Earnings Must Prove
- Oracle Is One Step From Junk—Can It Afford the AI Boom?
- Qualcomm Stock Slides 30%: Buying Opportunity Ahead of July 29 Earnings
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.
